Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma. | Neoplasia | 2023 | 37778252 | PubTator, text mining | PubMed |
| Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer. | BMC Complement Med Ther | 2023 | 37770919 | PubTator, text mining | PubMed |
| Elucidating the development, characterization, and antitumor potential of a novel humanized antibody against Trop2. | Int J Biol Macromol | 2023 | 37769779 | PubTator, text mining | PubMed |
| Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer. | Biologics | 2023 | 37767463 | PubTator, text mining | PubMed |
| Applications of Curcumin and Its Nanoforms in the Treatment of Cancer. | Pharmaceutics | 2023 | 37765192 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. | J Pers Med | 2023 | 37763107 | PubTator, text mining | PubMed |
| The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions. | J Clin Med | 2023 | 37762952 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Breast Cancer: Current Status and Future Directions. | Int J Mol Sci | 2023 | 37762027 | PubTator, text mining | PubMed |
| Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer. | Int J Mol Sci | 2023 | 37761978 | PubTator, text mining | PubMed |
| Multi-Faceted Role of Cancer-Associated Adipocytes in Colorectal Cancer. | Biomedicines | 2023 | 37760840 | PubTator, text mining | PubMed |
| Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking. | Cells | 2023 | 37759475 | PubTator, text mining | PubMed |
| Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer. | J Funct Biomater | 2023 | 37754880 | PubTator, text mining | PubMed |
| Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors. | Clin Cancer Res | 2023 | 37747807 | PubTator, text mining | PubMed |
| Unveiling novel insights in prostate cancer through single-cell RNA sequencing. | Front Oncol | 2023 | 37746302 | PubTator, text mining | PubMed |
| Uncovering therapeutic opportunities in the clinical development of antibody-drug conjugates. | Clin Transl Med | 2023 | 37740463 | PubTator, text mining | PubMed |
| Recent advances and future perspectives in the therapeutics of prostate cancer. | Exp Hematol Oncol | 2023 | 37740236 | PubTator, text mining | PubMed |
| Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options. | Drugs | 2023 | 37737434 | PubTator, text mining | PubMed |
| Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models. | J Clin Invest | 2023 | 37725435 | PubTator, text mining | PubMed |
| Recurrent Cystitis Associated With 2 Programmed Death 1 Inhibitors: A Rare Case Report and Literature Review. | J Immunother | 2023 | 37721343 | PubTator, text mining | PubMed |
| Analysis of Methylome, Transcriptome, and Lipid Metabolites to Understand the Molecular Abnormalities in Polycystic Ovary Syndrome. | Diabetes Metab Syndr Obes | 2023 | 37720421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=49